Skip to content

Omnicell OMCL Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Baxter International logo
Baxter InternationalBAX
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
Guardian Pharmacy Services logo
Guardian Pharmacy ServicesGRDN
ICU Medical logo
ICU MedicalICUI
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.75B-7.2%
Enterprise value$1.49B-0.4%
P/E113.2×
P/S1.4×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's operating lease right-of-use assets in other assets?
Omnicell (OMCL) reported operating lease right-of-use assets in other assets of $22.95M in Q1 2026.
How has Omnicell's operating lease right-of-use assets in other assets changed year-over-year?
Omnicell's operating lease right-of-use assets in other assets decreased by 21.6% year-over-year, from $29.29M to $22.95M.
What is the long-term trend for Omnicell's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Omnicell's operating lease right-of-use assets in other assets has grown at a -15.1% compound annual growth rate (CAGR), from $55.11M to $24.37M.